The Prognostic Value of Epidermal Growth Factor Receptor (EGFR) in Breast Cancer Patients: Results of a follow-up study on 149 patients

References

• Perez R, Betzholtz C, Westermark B. A frequent expression of growth factors for mesenchymal cells in human mammary carcinoma cell lines. Cancer Res 1987; 47: 3425–9
   Google Scholar
• Sainsbury J RC, Farndom J R, Needham G K. Epidermal growth factor receptor status as predictor for early recurrence of death from breast cancer. Lancet 1987; 1: 1398–402
   PubMed Web of Science ®Google Scholar
• Fitzpatrick S L, Brightwell J, Wittliff J L. Epidermal growth factor finding by breast tumour biopsies and relationship to estrogen receptor and progesterone receptor levels. Cancer Res 1984; 44: 3448–53
   PubMed Web of Science ®Google Scholar
• Nicholson S, Richard J, Sainsbury C. Epidermal growth factor receptor (EGFR); Results of 6-year follow-up study in operable breast cancer with emphasis on the node negative subgroup. Br J Cancer 1991; 63: 146–50
   PubMed Web of Science ®Google Scholar
• Reubi J C, Torhorst J. EGF receptors in human breast cancer on viable and necrotic tumour cells. Breast Cancer Res Treat 1988; 12: 245–6
   Google Scholar
• Van Dierendonck J H, Keijezer R, Van De Velde C JH, Cor-Nelisse C J. Nuclear distribution of the Ki-67 antigen during the cell cycle. Comparison with growth fraction in human breast cancer cells. Cancer Res 1989; 49: 2999–3002
   PubMed Web of Science ®Google Scholar
• Pekonen F, Partanen S, Mäkinen T, Rutanen E-M. Receptors of epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer. Cancer Res 1988; 48: 1343–6
   PubMed Web of Science ®Google Scholar
• Vihko R, Jänne O, Kontula K, Syrjälä P. Female sex steroid receptor status in primary and metastatic breast carcinoma and its relation to serum steroid and peptide hormone levels. Int J Cancer 1988; 26: 13–21
   Google Scholar
• Kaplan E, Meier P. Non parametric mation from incomplete observation. J Am Stat Assoc 1958; 53: 457
   Google Scholar
• Cox D R. Regression models and life tables. J R Stat Soc B 1972; 34: 187
   Google Scholar
• Fisher E R, Gregorio R M, Fisher B. The pathology of invasive breast cancer. Cancer 1975; 36: 1–85
   PubMed Web of Science ®Google Scholar
• Silvestrini R S, Diadone M G, Gasparini G. Cell kinetics as a prognostic marker in node negative breast cancer. Cancer 1985; 56: 1982–7
   PubMed Web of Science ®Google Scholar
• Goodson W, Ljung B-M, Waldman F. In vivo measurement of breast cancer growth rate. Arch Surg 1991; 126: 1220–4
   Google Scholar
• Fisher B, Remond C, Fisher E R, Caplan R. National Surgical Adjuvant Breast and Bowel Project. Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients; Findings from NSABBP Project Protocol B-06. J Clin Oncol 1988; 6: 1076–87
   PubMed Web of Science ®Google Scholar
• Alexieva-Figush J, van Putten W LJ, Blankenstein M A, van der WijstKlijn Blonk JGM. The prognostic value and relationship of patients characteristics, estrogen and progestine receptors, and site of relapse in primary breast cancer. Cancer 1988; 61: 758–68
   Google Scholar
• Foekens J A, Portengen H, van Putten W LJ. Prognostic value of estrogen and progesterone receptors measured by immunoassays in human breast cancer cytosols. Cancer Res 1989; 49: 5823–8
   PubMed Web of Science ®Google Scholar
• Isola J J, Helin H J, Helle M J, Kallioniemi O-P. Evaluation of cell proliferation in breast carcinoma. Comparison of Ki-67 immunohistochemical study, DNA fiow-cytometric analysis and mitotic count. Cancer 1990; 65: 1180–4
   PubMed Web of Science ®Google Scholar
• Klijn J GM, Foekens J A. Epidermal growth factor receptors (EGFR) in breast cancer. Ann Oncol 1990; 1: 231–5
   Google Scholar
• Toi E, Toi M, Osaki A, Yamada H, Toge T. Epidermal growth factor expression as a prognostic indicator in breast cancer. Eur J Cancer 1991; 27: 977–80
   PubMed Web of Science ®Google Scholar
• Koenders P G, Beex L V, Geurs-Moespot A, Heuvel J J, Kien-Huis C B, Benraad T J. Epidermal growth factor negative tumours are predominantly confined to the subgroup of estradiol receptor positive human primary breast cancers. Cancer Res 1991; 51: 4544–8
   PubMed Web of Science ®Google Scholar
• Lewis S, Locker A, Todd J H. Expression of EGFR in breast cancer. J Clin Pathol 1990; 43: 385–9
   PubMed Web of Science ®Google Scholar
• Bevilacqua P, Gasparini G, Dal-Fior S, Corradi G. Immuno-cytochemical determination of epidermal growth factor receptor with monoclonal EGFR1 antibody in primary breast cancer patients. Oncology 1990; 47: 313–7
   Google Scholar
• Toi M, Hamada Y, Nakamura T. Immunocytochemical and biochemical analysis of epidermal growth factor expression in human breast cancer tissues. Relationship to estrogen receptor and lymphatic invasion. Int J Cancer 1989; 43: 220–5
   Google Scholar
• Toi M, Nakamura T, Mukaida H. Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer. Cancer 1990; 65: 1908–14
   Google Scholar
• Russo J, Frederick J, Ownby H E. Predictors of recurrence and survival of patients with breast cancer. J Clin Pathol 1987; 88: 123–5
   Google Scholar
• Bolla M, Chedin M, Colonna M, Rostaing-Puissant B. Cham-baz E. Prognostic value of epidermal growth factor receptor in a series of 303 breast cancers. Eur J Cancer 1992; 28: 1052–4
   Google Scholar